Digital Health in Pharma News
NVIDIA and Cognizant Announce AI Pharma Partnership
Cognizant is advancing the application of generative AI (gen AI) technology with the NVIDIA BioNeMo platform to solve complex challenges of drug discovery in the life sciences industry. Read more
19 Mar 2024
Cognizant and Microsoft to Collaborate
Cognizant and Microsoft are collaborating to infuse generative AI into healthcare administration. This new, collaboration aims to increase productivity and efficiency for healthcare payers and providers. Read more
6 Mar 2024
RSSL Announces New Innovation Hub
RSSL have announced plans to launch its new Innovation Hub, a dedicated platform to help small- and medium-sized biotech organisations de-risk and accelerate the development of cutting-edge products. Read more
21 Feb 2024
BioLizard Announce Swiss Subsidiary and Service Offering for AI-Powered Digital Transformation of Life Science
BioLizard have announced the incorporation of BioLizard SA and the opening of new offices at Biopôle in Lausanne, home to one of the largest biotech hubs in Switzerland. Read more
23 Jan 2024
Scopus AI to Help Researchers Navigate the World of Research
Elsevier, a global leader in scientific information and data analytics, has launches Scopus AI – a generative AI product to help researchers and research institutions get fast and accurate summaries and research insights. Read more
16 Jan 2024
Iktos and Nerviano Medical Sciences Announce AI Collaboration
Iktos and Nerviano Medical Sciences S.r.l have announced a collaboration agreement in AI for unprecedented kinase project. Read more
9 Jan 2024
AI for Pharma Companies: The Role of Legal Departments
Jerry Temko, Managing Director, In-House Counsel Group, Major, Lindsey & Africa explores how Life science companies are becoming more alive to the role that in-house legal teams will play in safely and successfully taking on the AI challenge. Read more
22 Sep 2023
Future Pharma: How digital transformation will revolutionise our time-to-market
Developing new drugs is expensive and time-consuming, yet, digital manufacturing techniques are delivering significant benefits without compromising on quality, as Eric Flynn, Head of Pharmaceuticals and Life Sciences at Siemens GB&I explains. Read more
22 Jun 2023
Key driver identification: Minimising variability in biopharmaceutical production
Neelanjan Sengupta explores Key driver identification: Minimising variability in biopharmaceutical production in our latest issue of EPM. Read more
21 Jun 2023
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
NVIDIA and Cognizant Announce AI Pharma Partnership
Cognizant is advancing the application of generative AI (gen AI) technology with the NVIDIA BioNeMo platform to solve complex challenges of drug discovery in the life sciences industry. Read more
19 Mar 2024
Vicore Announces FDA Breakthrough Device Designation for Almee
Vicore Pharma Holding AB have announced FDA Breakthrough Device Designation status for Almee, a 9-week digital cognitive behavioural therapy (CBT), to be used as an adjunct treatment of anxiety symptoms related to PF. Read more
19 Mar 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Orchard Therapeutics Receives FDA Approval of Lenmeldy
Orchard Therapeutics, recently acquired by Kyowa Kirin, have announced the U.S. FDA has approved Lenmeldy for the treatment of children with early-onset—metachromatic leukodystrophy. Read more
19 Mar 2024
Fusion Pharmaceuticals to be Acquired by AstraZeneca
Fusion Pharmaceuticals, a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines, have announced the Company has entered into a definitive agreement to be acquired by AstraZeneca. Read more
19 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Bluebird Bio Secures up to $175 Million Debt Financing
Bluebird Bio has entered into a $175 million five-year, term loan facility with Hercules Capital. The transaction strengthens the Company’s balance sheet as it executes on the commercial launches for its three FDA approved gene therapies. Read more
19 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Novartis Invest $256 million in Singapore Biopharmaceutical Manufacturing Facility
Novartis recently announced it broke ground for the $256 million expansion of its biopharmaceutical manufacturing plant in Singapore. Read more
18 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25